Data Helps European CBD Firms Navigate the Nascent Industry

February 28, 2020 16:00:18

The past few years have seen significant developments for cannabis, both medical and recreational. At the forefront is cannabidiol, a chemical produced by hemp. It is one of over 100 cannabinoids said to be flush with medicinal properties, and it has become increasingly popular, with experts estimating the CBD market may be worth $20 billion by 2024.

Cannabidiol’s medical abilities are said to be wide-ranging. Users claim the hemp extract offers relief from a variety of ailments, including chronic pain, high blood pressure, and anxiety. Despite there being little scientific research backing…


About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published:

Do you have a questions or are you interested in working with CNW? Ask Our Editor

Denver, Colorado
303.498.7722 Office

CBDWire is part of the InvestorBrandNetwork.